Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoChange DetectedA notice above the site navigation announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page shows a new revision (v3.7.0) and a large portion of the previous study content has been removed, including drug-related details and key study sections, reshaping how the study details are presented.SummaryDifference13%

- Check66 days agoChange DetectedThe site revision metadata was updated from v3.6.5 to v3.6.6, reflecting a new software build on the page.SummaryDifference0.1%

Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.